ADXN
Price
$9.13
Change
-$0.07 (-0.76%)
Updated
Jul 2, 12:24 PM (EDT)
Capitalization
9.96M
PHAT
Price
$8.92
Change
+$0.07 (+0.79%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
617.85M
35 days until earnings call
Interact to see
Advertisement

ADXN vs PHAT

Header iconADXN vs PHAT Comparison
Open Charts ADXN vs PHATBanner chart's image
Addex Therapeutics
Price$9.13
Change-$0.07 (-0.76%)
Volume$900
Capitalization9.96M
Phathom Pharmaceuticals
Price$8.92
Change+$0.07 (+0.79%)
Volume$32.14K
Capitalization617.85M
ADXN vs PHAT Comparison Chart in %
Loading...
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADXN vs. PHAT commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Buy and PHAT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ADXN: $9.13 vs. PHAT: $8.91)
Brand notoriety: ADXN and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 174% vs. PHAT: 35%
Market capitalization -- ADXN: $9.96M vs. PHAT: $617.85M
ADXN [@Biotechnology] is valued at $9.96M. PHAT’s [@Biotechnology] market capitalization is $617.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 1 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ADXN’s FA Score: 1 green, 4 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, ADXN is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 5 TA indicator(s) are bullish while PHAT’s TA Score has 5 bullish TA indicator(s).

  • ADXN’s TA Score: 5 bullish, 2 bearish.
  • PHAT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ADXN is a better buy in the short-term than PHAT.

Price Growth

ADXN (@Biotechnology) experienced а -0.33% price change this week, while PHAT (@Biotechnology) price change was -8.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

ADXN is expected to report earnings on May 15, 2025.

PHAT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($618M) has a higher market cap than ADXN($9.96M). ADXN YTD gains are higher at: 30.429 vs. PHAT (9.729). ADXN has higher annual earnings (EBITDA): -12.19M vs. PHAT (-272.12M). PHAT has more cash in the bank: 212M vs. ADXN (3.35M). ADXN has less debt than PHAT: ADXN (43.8K) vs PHAT (204M). PHAT has higher revenues than ADXN: PHAT (81.9M) vs ADXN (556K).
ADXNPHATADXN / PHAT
Capitalization9.96M618M2%
EBITDA-12.19M-272.12M4%
Gain YTD30.4299.729313%
P/E RatioN/AN/A-
Revenue556K81.9M1%
Total Cash3.35M212M2%
Total Debt43.8K204M0%
TECHNICAL ANALYSIS
Technical Analysis
ADXNPHAT
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSLR170.677.71
+4.73%
First Solar
ARQQ35.600.92
+2.67%
Arqit Quantum Inc
GSBC61.800.85
+1.39%
Great Southern Bancorp
WNS65.120.49
+0.76%
WNS (Holdings) Limited
SGD0.78-0.04
-4.32%
Safe and Green Development Corporation

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
-0.76%
ANVS - ADXN
43%
Loosely correlated
+2.15%
CVM - ADXN
39%
Loosely correlated
+6.33%
PHAT - ADXN
28%
Poorly correlated
+0.68%
SGMO - ADXN
27%
Poorly correlated
-0.73%
MOLN - ADXN
26%
Poorly correlated
+1.35%
More